Insider Trading
Filed: 2026-04-07
Key Insights
- Shane Bohnen, the SVP and General Counsel of Bio-Techne Corp, exercised 2,259 stock options and sold 740 shares, reducing his direct ownership to 5,904 shares.
- Bohnen holds a variety of equity-based compensation including stock options, restricted stock units, and performance-based awards, indicating the company's commitment to long-term incentive compensation.
- The transaction occurred on April 3, 2026, which is relatively early in the year, potentially suggesting regular portfolio rebalancing or liquidity needs rather than a major shift in Bohnen's outlook on the company.